Abstract Body

Significant advances in TB control are needed to achieve the global EndTB goals by 2035. The global incidence of tuberculosis (TB) will need to decline by 17% annually, but is currently declining by only 1.5% per year. Transmission of TB is the major driver the global epidemic, particularly in high burden countries. Transmission not only leads to new infections, but also undermines preventive therapy when individuals becoming reinfected after completing a course of preventive treatment. Despite its important role, insufficient emphasis has been placed on studying TB transmission and implementing transmission control measures. The advent of genotyping methods 30 years ago provided an important tool for investigating and confirming transmission; however. genotyping has primarily been utilized in high-income countries where TB incidence is low. Among molecular epidemiology studies that have been performed in high-TB incidence settings, many have suggested that transmission due to casual contact in the community may account for a substantial proportion of TB cases. Whole genome sequencing represents the next-generation of genotyping techniques and holds promise to further advance our understanding of TB transmission by providing significantly greater discrimination. This talk will review recent studies utilizing whole genome sequencing in low- and high-TB incidence settings and the advances that may be achieved with this powerful tool.